| Product NDC: | 50114-1103 |
| Proprietary Name: | Pulsatilla Compositum |
| Non Proprietary Name: | PULSATILLA VULGARIS and SULFUR and CORTISONE ACETATE |
| Active Ingredient(s): | 18; 6; 8 [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg & nbsp; PULSATILLA VULGARIS and SULFUR and CORTISONE ACETATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50114-1103 |
| Labeler Name: | Heel Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20030831 |
| Package NDC: | 50114-1103-2 |
| Package Description: | 30000 mg in 1 BOTTLE (50114-1103-2) |
| NDC Code | 50114-1103-2 |
| Proprietary Name | Pulsatilla Compositum |
| Package Description | 30000 mg in 1 BOTTLE (50114-1103-2) |
| Product NDC | 50114-1103 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | PULSATILLA VULGARIS and SULFUR and CORTISONE ACETATE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20030831 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | Heel Inc |
| Substance Name | CORTISONE ACETATE; PULSATILLA VULGARIS; SULFUR |
| Strength Number | 18; 6; 8 |
| Strength Unit | [hp_X]/300mg; [hp_X]/300mg; [hp_X]/300mg |
| Pharmaceutical Classes |